Stay updated with breaking news from Repligen Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dana Investment Advisors Inc. lowered its stake in Repligen Co. (NASDAQ:RGEN – Free Report) by 36.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,437 shares of the biotechnology company’s stock after selling 2,546 shares during the period. Dana Investment Advisors […]
Dana Investment Advisors Inc. lessened its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 36.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,437 shares of the biotechnology company’s stock after selling 2,546 shares during […]
WealthPlan Investment Management LLC purchased a new stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,320 shares of the biotechnology company’s stock, valued at approximately $210,000. A number of other hedge […]
Repligen Co. (NASDAQ:RGEN – Free Report) – Stock analysts at William Blair cut their Q1 2024 earnings per share (EPS) estimates for shares of Repligen in a research report issued to clients and investors on Thursday, February 22nd. William Blair analyst M. Larew now forecasts that the biotechnology company will earn $0.30 per share for […]
Primecap Management Co. CA boosted its position in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 6.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 50,629 shares of the biotechnology company’s stock after purchasing an additional 3,250 shares […]